YUCAIPA, Calif., Jan. 28, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading manufacturer of respiratory medical devices, recently announced today that it has officially signed a contract with the Texas-based KGMA Business Solutions for pursuing U.S. Government contracts. KGMA maintains relationships with thousands of contracting and small business specialists within the Federal Government.
KGMA had prepared and submitted the GSA application for Ingen on September 22, 2009. The application has been under review with the VA National Acquisition Center, and was delayed back in November 2009 due to facility reorganization with the VA National Acquisition Center.
KGMA has recently displayed a highly strong confidence level that the application is near completion and will be approved. Kenneth Kurk, CEO of KGMA, suggested last week that Ingen move forward with a consulting agreement so that KGMA can begin the ground work required to assist Ingen with U.S. Federal Government Business Development efforts and preparation for the marketing and development with the preparation of a Corporate Capabilities Statement, develop contracting tools thru the General Services Administration (GSA) Schedules and viable teaming partners arrangements, conduct site visit meetings to market client capabilities to Federal Contracting personnel, market analysis and due diligence to qualify Federal Contract opportunities, and support the development, management and compliance of a Technical Proposal submissions for contract award evaluation.
“We look forward to working with Kenneth Kurk and his professional staff at KGMA. With more than 300 VA Hospitals in the USA, and even a larger market with the Department of Defense and several other government agencies, the Oxyview product line will be cataloged with GSA and KGMA will target and close various distribution channels,” stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
http://www.oxyviewnasalcannula.com/AboutUs.html
About Ingen:
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company has domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the Oxyview Nasal Cannula was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced the Oxyview Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.